In recent years, cannabinoids—the active chemicals in medical marijuana— have
Radiation of mobile phones affect the development of cancer, scientists say
American biologists have stated about new potential evidence that radio
Supplements with antioxidants can accelerate the growth of malignant tumors
There’s new evidence of a link between bioactive additives with
Thailand blazes ahead with push to legalise medical marijuana use
Thailand is rolling out plans to legalise medical marijuana, an
Researchers examine prescription opioid use in patients with chronic kidney disease
Adults with chronic kidney disease (CKD) have not been immune
He grabbed me and shouted “get Out!”: My life with a dementia patient man
“My Good,” he calls them. Your name he has forgotten.
Down with fat and stereotypes: 5 myths about liposuction
Fell asleep, woke up, and the excess fat is gone!
This Influencer Is Candidly Documenting Her Battle With Depression: ‘I Belong to a Club I Never Asked to Join’
Depression is a challenging condition to manage. People living with
Playing video games to cope with anxiety may increase risk for addiction
People play video games for different reasons. Some play for
Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Paclitaxel to Assess Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced or Metastatic Solid Tumors
WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 23, 2018– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a